SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

15 May 2023 Evaluate
The sales is pegged at Rs. 729.42 millions for the March 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 782.13 millions during the year-ago period.A slim rise of 8.54% was recorded in the Net profit for the quarter ended March 2023 to Rs. 85.29  millions  From Rs. 78.58 millions.Operating Profit saw a handsome growth to 133.21 millions from 122.72 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 729.42 782.13 -6.74 2750.52 3186.67 -13.69 2750.52 3186.67 -13.69
Other Income 26.86 22.79 17.86 76.12 126.40 -39.78 76.12 126.40 -39.78
PBIDT 133.21 122.72 8.55 356.96 782.09 -54.36 356.96 782.09 -54.36
Interest 3.22 3.74 -13.90 11.97 15.62 -23.37 11.97 15.62 -23.37
PBDT 129.99 118.98 9.25 344.99 766.47 -54.99 344.99 766.47 -54.99
Depreciation 19.17 18.80 1.97 78.99 76.73 2.95 78.99 76.73 2.95
PBT 110.82 100.18 10.62 266.00 689.74 -61.43 266.00 689.74 -61.43
TAX 25.53 21.60 18.19 64.81 167.28 -61.26 64.81 167.28 -61.26
Deferred Tax -3.97 -8.90 -55.39 -7.29 -4.22 72.75 -7.29 -4.22 72.75
PAT 85.29 78.58 8.54 201.19 522.46 -61.49 201.19 522.46 -61.49
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 18.26 15.69 16.39 12.98 24.54 -47.12 12.98 24.54 -47.12

NGL Fine-Chem Share Price

2327.95 98.20 (4.40%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×